| Cover | Sep. 25, 2024 |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Sep. 25, 2024 |
| Current Fiscal Year End Date | --12-31 |
| Entity File Number | 001-40877 |
| Entity Registrant Name | CERO THERAPEUTICS HOLDINGS, INC. |
| Entity Central Index Key | 0001870404 |
| Entity Tax Identification Number | 87-1088814 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 201 Haskins Way |
| Entity Address, Address Line Two | Suite 230 |
| Entity Address, City or Town | South San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94080 |
| City Area Code | 650 |
| Local Phone Number | 407-2376 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, par value $0.0001 per share | |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | CERO |
| Security Exchange Name | NASDAQ |
| Warrants, each whole warrant exercisable for one share of common stock | |
| Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of common stock |
| Trading Symbol | CEROW |
| Security Exchange Name | NASDAQ |
